Sector : Pharmaceuticals
BSE
634.60 -0.67%
NSE
634.60 -0.66 %
Jun 29, 15:52
Cipla shares gain 2% on partnership with a German firm for anti-diabetic drugs
Jun 24, 20:38
Cipla-BDR Pharmaceuticals eyeing early approval of Favipiravir
Jun 23, 22:06
Cipla to price generic version of COVID-19 drug remdesivir at less than Rs 5,000 per vial
Jun 23, 13:05
Cipla shares end almost 3% higher on regulator nod to manufacture remdesivir
Jul 03, 20:00
Jul 02, 20:00
Jul 06, 15:45
Price
BSE
634.60 -0.67%
NSE
634.60 -0.66%
Share Target
Target(Rs)
Tip Period
Stop Loss
Your permanent Nickname can be distinct from your username and no one need know the link between the two.
